Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tadalafil as an Adjuvant to Therapy for Duchenne Muscular Dystrophy

NCT05195775 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT05195775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05195775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tadalafil as an Adjuvant to Therapy for Duchenne Muscular Dystrophy
Lead sponsor
University of Florida
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
December 14, 2021
Completion date
September 5, 2025
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy